RE: Avoid these scammers28 Mar 2021 13:03
I don't have any sort of background in the science to determine if the Virolens technology is for real. So here's my take on this:
The bull case:
1. The test has regulatory approval. Would this happen if the results data was poor?
2. Tech giants Dell and Intel have thrown their weight behind this technology. Would they really get involved if it were a scam? One would presume they have done their due diligence.
3. The Heathrow trials seem to have been a success with the airport CEO voicing his approval. One would assume they tested a significant number of people during that 3 week period to get an idea if it works. If the data had been poor would they really have proceeded with the regulatory approval process?
The bear case:
1. Very little is known about the start up iAbra behind this. Seems a bit far fetched that a few guys could develop this technology themselves, where well funded global behemoths have so far failed.
2. The press release in September and subsequent put down by the FT did not help the PR case.
All things being taken into consideration, in terms of risk/reward I feel this is definitely worth a punt. TTG is a solid, growing business with the current price being a reasonable reflection of the prospects of the underlying business. The downside if Virolens fails is not huge in my opinion, maybe 15-20%. Now, on the other hand if this takes off, the upside is multiples of that.
*I have a position.